维生素D在偏头痛临床治疗效果中的系统综述
A Systematic Review of the Effects of Vitamin D in the Clinical Treatment of Migraine
DOI: 10.12677/acm.2024.14123052, PDF,   
作者: 李楚翘:格拉斯哥大学医学兽医学和生命科学学院,英国 格拉斯哥
关键词: 维生素D偏头痛临床治疗Vitamin D Migraine Clinical Treatment
摘要: 目前偏头痛的研究表明,维生素D逐渐成为一种可行的治疗策略。然而,由于偏头痛的发病机制尚未完全明确,维生素D干预偏头痛的理论支持并不充分,补充维生素D能否改善偏头痛患者的临床症状仍存在争议。本研究采用RevMan5软件对1980年1月至2021年7月有关补充维生素D治疗偏头痛的研究文献进行了评估。作者使用Cochrane干预评估和NOS量表标准独立对Web of Science、Embase、Medline、PubMed和Cochrane Library进行系统检索,六项研究,共涉及389名偏头痛患者。收集的数据显示,与对照组相比,维生素D能有效降低偏头痛严重程度(P = 0.005)、偏头痛持续时间(P = 0.0004)、偏头痛天数/月(P = 0.0002)和偏头痛频率(月) (P = 0.01)。这表明维生素D的干预治疗对改善偏头痛的临床症状有良好效果。
Abstract: Currently, research on migraines suggests that vitamin D is becoming a viable treatment strategy. However, as the pathogenesis of migraine is not completely clear, the theoretical support of vitamin D intervention in migraine is not much sufficient, and it is still controversial whether vitamin D supplementation can improve the clinical symptoms of migraine patients. This systematic review evaluated the literature on studies of vitamin D supplementation for migraine using a meta-analysis from January 1980 to July 2021 using RevMan5 software. A systematic search of Web of Science, Embase, Medline, PubMed and Cochrane Library has been performed independently by the author using Cochrane intervention evaluation and NOS scale criteria. This systematic review included six studies involving 389 migraine patients. The data collected showed that: compared with the control group, vitamin D supplementation was effective in reducing migraine severity (P = 0.005), duration of migraine (P = 0.0004), migraine days/month (P = 0.0002) and migraine frequency (month) (P = 0.01). It is concluded that the intervention therapy of vitamin D supplement has a good effect on improving the clinical symptoms of migraine.
文章引用:李楚翘. 维生素D在偏头痛临床治疗效果中的系统综述[J]. 临床医学进展, 2024, 14(12): 96-107. https://doi.org/10.12677/acm.2024.14123052

参考文献

[1] Evers, S. (2015) Früher als Symptom überspannter Menschen abgestempelt. Migräne—Wenn der Kopf zu platzen droht. MMWFortschritte der Medizin, 157, 68-71. [Google Scholar] [CrossRef] [PubMed]
[2] Pelzer, N., Louter, M.A., van Zwet, E.W., Nyholt, D.R., Ferrari, M.D., van den Maagdenberg, A.M., et al. (2018) Linking Migraine Frequency with Family History of Migraine. Cephalalgia, 39, 229-236. [Google Scholar] [CrossRef] [PubMed]
[3] Munoz-Ceron, J., Marin-Careaga, V., Peña, L., Mutis, J. and Ortiz, G. (2019) Headache at the Emergency Room: Etiologies, Diagnostic Usefulness of the ICHD 3 Criteria, Red and Green Flags. PLOS ONE, 14, e0208728. [Google Scholar] [CrossRef] [PubMed]
[4] von Brevern, M. and Lempert, T. (2016) Vestibular Migraine. Handbook of Clinical Neurology, 137, 301-316. [Google Scholar] [CrossRef] [PubMed]
[5] Blumenfeld, A.E., Victorio, M.C. and Berenson, F.R. (2016) Complicated Migraines. Seminars in Pediatric Neurology, 23, 18-22. [Google Scholar] [CrossRef] [PubMed]
[6] Schwedt, T.J. (2014) Chronic Migraine. BMJ, 348, g1416. [Google Scholar] [CrossRef] [PubMed]
[7] Leadley, R.M., Armstrong, N., Lee, Y.C., Allen, A. and Kleijnen, J. (2012) Chronic Diseases in the European Union: The Prevalence and Health Cost Implications of Chronic Pain. Journal of Pain & Palliative Care Pharmacotherapy, 26, 310-325. [Google Scholar] [CrossRef] [PubMed]
[8] Mayans, L. and Walling, A. (2018) Acute Migraine Headache: Treatment Strategies. American Family Physician, 97, 243-251.
[9] Lisicki, M. and Schoenen, J. (2020) Metabolic Treatments of Migraine. Expert Review of Neurotherapeutics, 20, 295-302. [Google Scholar] [CrossRef] [PubMed]
[10] Ha, H. and Gonzalez, A. (2019) Migraine Headache Prophylaxis. American Family Physician, 99, 17-24.
[11] Digre, K.B. (2019) What’s New in the Treatment of Migraine? Journal of Neuro-Ophthalmology, 39, 352-359. [Google Scholar] [CrossRef] [PubMed]
[12] Motaghi, M., Haghjooy Javanmard, S., Haghdoost, F., Tajadini, M., Saadatnia, M., Rafiee, L., et al. (2013) Relationship between Vitamin D Receptor Gene Polymorphisms and Migraine without Aura in an Iranian Population. BioMed Research International, 2013, Article ID: 351942. [Google Scholar] [CrossRef] [PubMed]
[13] Celikbilek, A., Gocmen, A.Y., Zararsiz, G., Tanik, N., Ak, H., Borekci, E., et al. (2014) Serum Levels of Vitamin D, Vitamin D-Binding Protein and Vitamin D Receptor in Migraine Patients from Central Anatolia Region. International Journal of Clinical Practice, 68, 1272-1277. [Google Scholar] [CrossRef] [PubMed]
[14] Putz, Z., Martos, T., Németh, N., Körei, A.E., Szabó, M., Vági, O.E., et al. (2013) Vitamin D and Neuropathy. Orvosi Hetilap, 154, 2012-2015. [Google Scholar] [CrossRef] [PubMed]
[15] Ketharanathan, V., Torgersen, G.R., Petrovski, B.É. and Preus, H.R. (2019) Radiographic Alveolar Bone Level and Levels of Serum 25-OH-Vitamin D3 in Ethnic Norwegian and Tamil Periodontitis Patients and Their Periodontally Healthy Controls. BMC Oral Health, 19, Article No. 83. [Google Scholar] [CrossRef] [PubMed]
[16] Isa, H., Almaliki, M., Alsabea, A. and Mohamed, A. (2020) Vitamin D Deficiency in Healthy Children in Bahrain: Do Gender and Age Matter? Eastern Mediterranean Health Journal, 26, 260-267. [Google Scholar] [CrossRef] [PubMed]
[17] Ghorbani, Z., Togha, M., Rafiee, P., Ahmadi, Z.S., Rasekh Magham, R., Haghighi, S., et al. (2019) Vitamin D in Migraine Headache: A Comprehensive Review on Literature. Neurological Sciences, 40, 2459-2477. [Google Scholar] [CrossRef] [PubMed]
[18] Patel, U., Kodumuri, N., Malik, P., Kapoor, A., Malhi, P., Patel, K., et al. (2019) Hypocalcemia and Vitamin D Deficiency Amongst Migraine Patients: A Nationwide Retrospective Study. Medicina, 55, Article 407. [Google Scholar] [CrossRef] [PubMed]
[19] Jacobs, E.T. and Mullany, C.J. (2015) Vitamin D Deficiency and Inadequacy in a Correctional Population. Nutrition, 31, 659-663. [Google Scholar] [CrossRef] [PubMed]
[20] Arzani, M., Jahromi, S.R., Ghorbani, Z., Vahabizad, F., Martelletti, P., Ghaemi, A., et al. (2020) Gut-Brain Axis and Migraine Headache: A Comprehensive Review. The Journal of Headache and Pain, 21, Article No. 15. [Google Scholar] [CrossRef] [PubMed]
[21] Khorvash, F., Askari, G., Maracy, M.R., Ghiasvand, R., Maghsoudi, Z. and Iraj, B. (2013) The Relationship between Serum Levels of Vitamin D and Migraine. Journal of Research in Medical Sciences, 18, S66-S70.
[22] Celikbilek, A., Gocmen, A.Y., Zararsiz, G., Tanik, N., Ak, H., Borekci, E., et al. (2014) Serum Levels of Vitamin D, Vitamin D-Binding Protein and Vitamin D Receptor in Migraine Patients from Central Anatolia Region. International Journal of Clinical Practice, 68, 1272-1277. [Google Scholar] [CrossRef] [PubMed]
[23] Todd, C., Lagman-Bartolome, A.M. and Lay, C. (2018) Women and Migraine: The Role of Hormones. Current Neurology and Neuroscience Reports, 18, Article No. 42. [Google Scholar] [CrossRef] [PubMed]
[24] Kjærgaard, M., Waterloo, K., Wang, C.E.A., Almås, B., Figenschau, Y., Hutchinson, M.S., et al. (2012) Effect of Vitamin D Supplement on Depression Scores in People with Low Levels of Serum 25-Hydroxyvitamin D: Nested Case—Control Study and Randomised Clinical Trial. British Journal of Psychiatry, 201, 360-368. [Google Scholar] [CrossRef] [PubMed]
[25] Zandifar, A., Masjedi, S.s., Banihashemi, M., Asgari, F., Manouchehri, N., Ebrahimi, H., et al. (2014) Vitamin D Status in Migraine Patients: A Case-Control Study. BioMed Research International, 2014, Article ID: 514782. [Google Scholar] [CrossRef] [PubMed]
[26] Rao, R. and Hershey, A.D. (2020) An Update on Acute and Preventive Treatments for Migraine in Children and Adolescents. Expert Review of Neurotherapeutics, 20, 1017-1027. [Google Scholar] [CrossRef] [PubMed]
[27] Greene, K., Irwin, S.L. and Gelfand, A.A. (2019) Pediatric Migraine: An Update. Neurologic Clinics, 37, 815-833. [Google Scholar] [CrossRef] [PubMed]
[28] Luedtke, K., Allers, A., Schulte, L.H. and May, A. (2015) Efficacy of Interventions Used by Physiotherapists for Patients with Headache and Migraine—Systematic Review and Meta-Analysis. Cephalalgia, 36, 474-492. [Google Scholar] [CrossRef] [PubMed]
[29] Lo, C.K., Mertz, D. and Loeb, M. (2014) Newcastle-ottawa Scale: Comparing Reviewers’ to Authors’ Assessments. BMC Medical Research Methodology, 14, Article No. 45. [Google Scholar] [CrossRef] [PubMed]
[30] Cayir, A., Turan, M.I. and Tan, H. (2014) Effect of Vitamin D Therapy in Addition to Amitriptyline on Migraine Attacks in Pediatric Patients. Brazilian Journal of Medical and Biological Research, 47, 349-354. [Google Scholar] [CrossRef] [PubMed]
[31] Buettner, C., Nir, R., Bertisch, S.M., Bernstein, C., Schain, A., Mittleman, M.A., et al. (2015) Simvastatin and Vitamin D for Migraine Prevention: A Randomized, Controlled Trial. Annals of Neurology, 78, 970-981. [Google Scholar] [CrossRef] [PubMed]
[32] Askari, G., Mottaghi, T., Khorvash, F. and Maracy, M. (2015) Effect of Vitamin D Supplementation on Symptoms and C-Reactive Protein in Migraine Patients. Journal of Research in Medical Sciences, 20, 477-482. [Google Scholar] [CrossRef] [PubMed]
[33] Gazerani, P., Fuglsang, R., Pedersen, J.G., Sørensen, J., Kjeldsen, J.L., Yassin, H., et al. (2018) A Randomized, Double-Blinded, Placebo-Controlled, Parallel Trial of Vitamin D3 Supplementation in Adult Patients with Migraine. Current Medical Research and Opinion, 35, 715-723. [Google Scholar] [CrossRef] [PubMed]
[34] Kılıç, B. and Kılıç, M. (2019) Evaluation of Vitamin D Levels and Response to Therapy of Childhood Migraine. Medicina, 55, Article 321. [Google Scholar] [CrossRef] [PubMed]
[35] Ghorbani, Z., Togha, M., Rafiee, P., Ahmadi, Z.S., Rasekh Magham, R., Djalali, M., et al. (2020) Vitamin D3 Might Improve Headache Characteristics and Protect against Inflammation in Migraine: A Randomized Clinical Trial. Neurological Sciences, 41, 1183-1192. [Google Scholar] [CrossRef] [PubMed]
[36] Jolliffe, D.A., Camargo Jr., C.A., Sluyter, J.D., Aglipay, M., Aloia, J.F., Ganmaa, D., et al. (2020) Vitamin D Supplementation to Prevent Acute Respiratory Infections: Systematic Review and Meta-Analysis of Aggregate Data from Radomised Controlled Trials. medRxiv.
[37] Prietl, B., Treiber, G., Pieber, T. and Amrein, K. (2013) Vitamin D and Immune Function. Nutrients, 5, 2502-2521. [Google Scholar] [CrossRef] [PubMed]
[38] Patrick, R.P. and Ames, B.N. (2015) Vitamin D and the Omega‐3 Fatty Acids Control Serotonin Synthesis and Action, Part 2: Relevance for ADHD, Bipolar Disorder, Schizophrenia, and Impulsive Behavior. The FASEB Journal, 29, 2207-2222. [Google Scholar] [CrossRef] [PubMed]
[39] Charoenngam, N. and Holick, M.F. (2020) Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients, 12, Article 2097. [Google Scholar] [CrossRef] [PubMed]